InsidersTradesSigma
Track the 漢田生技 stock price and the full management transaction log of the company, a publicly traded company based in Taiwan. Shares trade on the TW market, under the oversight of TWSE / TPEx (MOPS). Market capitalisation: €2bn. The latest transaction was reported on 17 June 2026 (Negotiated). Among the most active insiders: 曾士哲. Every trade is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
漢田生技 es una empresa que cotiza en el mercado XTAI, especializada en el sector de la biotecnología. Se centra en el desarrollo de soluciones innovadoras en el campo de la salud.